Table 2. Univariate Analysis.
Favorable | Unfavorable | Hazard ratio | P value | 95% confidence interval |
||
---|---|---|---|---|---|---|
Lower | Upper | |||||
Age | < 65 | ≥ 65 | 0.757 | 0.240 | 0.462 | 1.196 |
Gender | Female | Male | 0.328 | < 0.001 | 0.203 | 0.513 |
Smoking status | Never | Current/former | 0.349 | < 0.001 | 0.215 | 0.548 |
Histology | Adenocarcinoma | Others | 0.249 | < 0.001 | 0.164 | 0.380 |
pT status | pT1 | pT2-3 | 0.451 | < 0.001 | 0.299 | 0.685 |
pN status | pN0 | pN1-2 | 0.332 | < 0.001 | 0.212 | 0.536 |
CEA | Normal | High | 0.380 | < 0.001 | 0.251 | 0.584 |
CYFRA21-1 | Normal | High | 0.352 | < 0.001 | 0.229 | 0.555 |
ALI_CRP score | Score 0 | Others | 0.287 | < 0.001 | 0.177 | 0.451 |
ALI: advanced lung cancer inflammation index; CRP: C-reactive protein; CEA: carcinoembryonic antigen; CYFRA21-1: cytokeratin 19 fragments.